uniQure NV (QURE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1137916,
    "name": "uniQure NV",
    "stock_name": "uniQure NV",
    "full_name": "uniQure NV",
    "name_url": "stocks-analysis/uniqure-nv",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "22.74",
    "chg": -2.58,
    "chgp": "-10.19%",
    "dir": -1,
    "prev_price": "25.32",
    "mcapval": "956.33",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "NL0010696654",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "4.41 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/uniqure-nv-1137916-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "uniQure NV Faces Weak Start with 5.08% Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-faces-weak-start-with-508-gap-down-amid-market-concerns-3721538",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/uniQureNV_gapdown_3721538.png",
        "date": "2025-11-21 16:07:03",
        "description": "uniQure NV, a small-cap biotechnology firm, experienced a notable decline in its stock performance today, reflecting a significant downturn over the past month. Technical indicators present a mixed outlook, with contrasting signals from MACD and Bollinger Bands. The company's financial metrics reveal a complex situation for stakeholders."
      },
      {
        "title": "uniQure NV Hits Day High with 15.18% Surge Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-hits-day-high-with-1518-surge-amid-market-volatility-3698098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/uniQureNV_priceRelatedfactors_3698098.png",
        "date": "2025-11-13 16:29:42",
        "description": "uniQure NV's stock surged significantly today, contrasting with the modest rise of the S&P 500. Despite recent challenges, including a decline over the past week and month, the company has achieved impressive one-year returns. However, it faces operational difficulties, including negative EBITDA and debt servicing issues."
      },
      {
        "title": "uniQure NV Hits Day High with 17.93% Surge Amid Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-hits-day-high-with-1793-surge-amid-strong-intraday-performance-3693027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/uniQureNV_priceRelatedfactors_3693027.png",
        "date": "2025-11-12 16:35:26",
        "description": "uniQure NV, a small-cap biotechnology firm, saw a notable intraday gain today, contrasting with the S&P 500's modest rise. Despite a remarkable annual return, the company faces significant challenges, including operating losses, declining net sales, and a negative EBITDA, raising concerns about its financial stability."
      },
      {
        "title": "uniQure NV Hits Day Low of $26.25 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-hits-day-low-of-2625-amid-price-pressure-3680265",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/uniQureNV_priceRelatedfactors_3680265.png",
        "date": "2025-11-07 16:40:31",
        "description": "uniQure NV has faced notable volatility, with a significant stock decline today and a staggering drop over the past week. Financial metrics indicate challenges, including negative EBITDA and a low EBIT to interest ratio. The company's recent net sales also fell sharply, raising concerns about its market position."
      },
      {
        "title": "uniQure NV Faces Weak Start with 10.32% Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-faces-weak-start-with-1032-gap-down-amid-market-concerns-3712464",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/uniQureNV_gapdown_3712464.png",
        "date": "2025-11-07 16:24:55",
        "description": "uniQure NV, a small-cap biotechnology firm, opened with a notable loss, continuing a trend of significant declines over the past month. The company, which has a market capitalization of around USD 956 million and is currently loss-making, exhibits a unique financial structure with a high return on equity."
      },
      {
        "title": "uniQure NV Hits Day Low of $25.52 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-hits-day-low-of-2552-amid-price-pressure-3676148",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/uniQureNV_priceRelatedfactors_3676148.png",
        "date": "2025-11-06 16:19:09",
        "description": "uniQure NV faced significant stock volatility, dropping 24% in a challenging trading environment. The company reported a 52.71% decline in net sales, contributing to concerns about financial stability, including negative EBITDA and a troubling return on capital employed. Its operational inefficiencies further complicate its market position."
      },
      {
        "title": "uniQure NV Hits Day Low of $22.85 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-hits-day-low-of-2285-amid-price-pressure-3671571",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/uniQureNV_priceRelatedfactors_3671571.png",
        "date": "2025-11-04 18:31:16",
        "description": "uniQure NV has faced notable volatility, with a significant stock decline today and over the past week. Despite a remarkable year-over-year growth, the company is grappling with financial challenges, including operating losses and a substantial drop in net sales, raising concerns about its financial health."
      },
      {
        "title": "uniQure NV Hits New 52-Week High of $61.79, Surging 1014.68%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-hits-new-52-week-high-of-6179-surging-101468-3608042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/uniQureNV_priceRelatedfactors_3608042.png",
        "date": "2025-10-09 20:19:16",
        "description": "uniQure NV achieved a new 52-week high of USD 61.79 on October 8, 2025, reflecting a remarkable 1014.68% increase over the past year. Despite being a loss-making small-cap company in the Pharmaceuticals & Biotechnology sector, it has a market capitalization of USD 956 million and notable financial metrics."
      },
      {
        "title": "uniQure NV Hits Day High with 9.47% Surge Amid Strong Intraday Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/uniqure-nv-hits-day-high-with-947-surge-amid-strong-intraday-performance-3604449",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/uniQureNV_priceRelatedfactors_3604449.png",
        "date": "2025-10-08 17:24:38",
        "description": "uniQure NV, a small-cap biotechnology firm, saw its stock rise significantly on October 7, 2025, amid broader market gains. Despite impressive short-term stock performance, the company faces challenges, including a sharp decline in net sales and negative EBITDA, raising concerns about its financial health and debt servicing capabilities."
      }
    ],
    "total": 20,
    "sid": "1137916",
    "stock_news_url": "https://www.marketsmojo.com/news/uniqure-nv-1137916"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

uniQure NV Faces Weak Start with 5.08% Gap Down Amid Market Concerns

2025-11-21 16:07:03

uniQure NV, a small-cap biotechnology firm, experienced a notable decline in its stock performance today, reflecting a significant downturn over the past month. Technical indicators present a mixed outlook, with contrasting signals from MACD and Bollinger Bands. The company's financial metrics reveal a complex situation for stakeholders.

uniQure NV Hits Day High with 15.18% Surge Amid Market Volatility

2025-11-13 16:29:42

uniQure NV's stock surged significantly today, contrasting with the modest rise of the S&P 500. Despite recent challenges, including a decline over the past week and month, the company has achieved impressive one-year returns. However, it faces operational difficulties, including negative EBITDA and debt servicing issues.

uniQure NV Hits Day High with 17.93% Surge Amid Strong Intraday Performance

2025-11-12 16:35:26

uniQure NV, a small-cap biotechnology firm, saw a notable intraday gain today, contrasting with the S&P 500's modest rise. Despite a remarkable annual return, the company faces significant challenges, including operating losses, declining net sales, and a negative EBITDA, raising concerns about its financial stability.

uniQure NV Hits Day Low of $26.25 Amid Price Pressure

2025-11-07 16:40:31

uniQure NV has faced notable volatility, with a significant stock decline today and a staggering drop over the past week. Financial metrics indicate challenges, including negative EBITDA and a low EBIT to interest ratio. The company's recent net sales also fell sharply, raising concerns about its market position.

uniQure NV Faces Weak Start with 10.32% Gap Down Amid Market Concerns

2025-11-07 16:24:55

uniQure NV, a small-cap biotechnology firm, opened with a notable loss, continuing a trend of significant declines over the past month. The company, which has a market capitalization of around USD 956 million and is currently loss-making, exhibits a unique financial structure with a high return on equity.

uniQure NV Hits Day Low of $25.52 Amid Price Pressure

2025-11-06 16:19:09

uniQure NV faced significant stock volatility, dropping 24% in a challenging trading environment. The company reported a 52.71% decline in net sales, contributing to concerns about financial stability, including negative EBITDA and a troubling return on capital employed. Its operational inefficiencies further complicate its market position.

uniQure NV Hits Day Low of $22.85 Amid Price Pressure

2025-11-04 18:31:16

uniQure NV has faced notable volatility, with a significant stock decline today and over the past week. Despite a remarkable year-over-year growth, the company is grappling with financial challenges, including operating losses and a substantial drop in net sales, raising concerns about its financial health.

uniQure NV Hits New 52-Week High of $61.79, Surging 1014.68%

2025-10-09 20:19:16

uniQure NV achieved a new 52-week high of USD 61.79 on October 8, 2025, reflecting a remarkable 1014.68% increase over the past year. Despite being a loss-making small-cap company in the Pharmaceuticals & Biotechnology sector, it has a market capitalization of USD 956 million and notable financial metrics.

uniQure NV Hits Day High with 9.47% Surge Amid Strong Intraday Performance

2025-10-08 17:24:38

uniQure NV, a small-cap biotechnology firm, saw its stock rise significantly on October 7, 2025, amid broader market gains. Despite impressive short-term stock performance, the company faces challenges, including a sharp decline in net sales and negative EBITDA, raising concerns about its financial health and debt servicing capabilities.

View All News